These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 25773362

  • 1. Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema.
    Holm K, Schroeder M, Lövestam Adrian M.
    Doc Ophthalmol; 2015 Aug; 131(1):43-51. PubMed ID: 25773362
    [Abstract] [Full Text] [Related]

  • 2. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L, Cserhati S, Seidensticker F, Liegl R, Kampik A, Ulbig M, Neubauer AS, Kernt M.
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [Abstract] [Full Text] [Related]

  • 3. Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.
    Fu Y, Wang P, Meng X, Du Z, Wang D.
    Doc Ophthalmol; 2017 Dec; 135(3):165-173. PubMed ID: 28756595
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
    Retina; 2006 Dec; 26(9):999-1005. PubMed ID: 17151486
    [Abstract] [Full Text] [Related]

  • 5. Long-term full-field and multifocal electroretinographic changes after treatment with ranibizumab in patients with diabetic macular edema.
    Yigit K, Inan ÜÜ, Inan S, Dogan M, Yavas GF, Cetinkaya E.
    Int Ophthalmol; 2021 Apr; 41(4):1487-1501. PubMed ID: 33486648
    [Abstract] [Full Text] [Related]

  • 6. Diameter of retinal vessels in patients with diabetic macular edema is not altered by intravitreal ranibizumab (lucentis).
    Terai N, Haustein M, Siegel A, Stodtmeister R, Pillunat LE, Sandner D.
    Retina; 2014 Jul; 34(7):1466-72. PubMed ID: 24457978
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study).
    Comyn O, Sivaprasad S, Peto T, Neveu MM, Holder GE, Xing W, Bunce CV, Patel PJ, Egan CA, Bainbridge JW, Hykin PG.
    Am J Ophthalmol; 2014 May; 157(5):960-70. PubMed ID: 24531025
    [Abstract] [Full Text] [Related]

  • 8. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 9. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.
    Baget-Bernaldiz M, Romero-Aroca P, Bautista-Perez A, Mercado J.
    Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336
    [Abstract] [Full Text] [Related]

  • 10. The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.
    Nowacka B, Kirkiewicz M, Mozolewska-Piotrowska K, Lubiński W.
    Doc Ophthalmol; 2016 Apr; 132(2):111-22. PubMed ID: 27000269
    [Abstract] [Full Text] [Related]

  • 11. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
    Ozturk BT, Kerimoglu H, Bozkurt B, Okudan S.
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
    [Abstract] [Full Text] [Related]

  • 12. Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
    Santos AR, Gomes SC, Figueira J, Nunes S, Lobo CL, Cunha-Vaz JG.
    Ophthalmologica; 2014 Aug; 231(1):16-22. PubMed ID: 24280908
    [Abstract] [Full Text] [Related]

  • 13. Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
    Pearce I, Banerjee S, Burton BJ, Chakravarthy U, Downey L, Gale RP, Gibson J, Pagliarini S, Patel J, Sivaprasad S, Andrews C, Brittain C, Warburton J, RELIGHT Study Group.
    Ophthalmology; 2015 Sep; 122(9):1811-9. PubMed ID: 26150052
    [Abstract] [Full Text] [Related]

  • 14. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.
    Messias K, Barroso RM, Jorge R, Messias A.
    Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775
    [Abstract] [Full Text] [Related]

  • 15. Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression.
    Campochiaro PA, Khanani A, Singer M, Patel S, Boyer D, Dugel P, Kherani S, Withers B, Gambino L, Peters K, Brigell M, TIME-2 Study Group.
    Ophthalmology; 2016 Aug; 123(8):1722-1730. PubMed ID: 27236272
    [Abstract] [Full Text] [Related]

  • 16. A prospective randomized trial of intravitreal bevacizumab versus ranibizumab for the management of diabetic macular edema.
    Nepomuceno AB, Takaki E, Paes de Almeida FP, Peroni R, Cardillo JA, Siqueira RC, Scott IU, Messias A, Jorge R.
    Am J Ophthalmol; 2013 Sep; 156(3):502-510.e2. PubMed ID: 23795985
    [Abstract] [Full Text] [Related]

  • 17. Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.
    Pieramici DJ, Wang PW, Ding B, Gune S.
    Ophthalmology; 2016 Jun; 123(6):1345-50. PubMed ID: 26992841
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, Soubrane G.
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.
    Laugesen CS, Ostri C, Brynskov T, Lund-Andersen H, Larsen M, Vorum H, Sørensen TL.
    Acta Ophthalmol; 2017 Feb; 95(1):28-32. PubMed ID: 27473397
    [Abstract] [Full Text] [Related]

  • 20. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.
    Okamoto M, Yamashita M, Ogata N.
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.